Propanc Biopharma, Inc. (PPCB) earnings
PPCB earnings moved a median of -3.53% by the close. Quarterly and annual PPCB reports and results, each read against the price at its own news timestamp. Back to the PPCB overview →
15 measured PPCB earnings events.
Where these PPCB earnings landedvs 14 measured PPCB earnings reactions
| Middle 50% of PPCB earnings reactions | -7.64% to 0.00% |
|---|---|
| Median reaction (to close) | -3.53% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 PPCB earnings events with a measured close landed between -7.64% and +0.00%; 14% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K Propanc Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-K | -2.28% | -13.27% | |
| Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results | Press release | +1.53% | -5.56% | |
| Form 10-Q Propanc Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.53% | -5.56% | |
| Form 10-Q Propanc Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-Q | -6.82% | -0.04% | |
| Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results | Press release | -2.55% | -3.10% | |
| Form 10-Q Propanc Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.58% | +0.95% | |
| Form 10-K Propanc Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-K | +1.24% | -3.96% | |
| Form 10-Q Propanc Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-Q Propanc Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Propanc Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-K Propanc Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-K | +0.00% | -8.33% | |
| Form 10-Q Propanc Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -9.09% | |
| Form 10-Q Propanc Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-Q | +4.88% | +4.88% | |
| Form NT 10-Q Propanc Biopharma, Inc. For: Dec 31 | SEC filing · Form NT | — | +0.00% | |
| Form 10-Q Propanc Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -18.78% |
Keep exploring
More PPCB: analyst actions → · SEC filings → · PPCB overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 144 | -0.46% | 41% |
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
| Cara Therapeutics, Inc. (CARA) | 143 | -0.56% | 46% |
| Nutriband Inc. (NTRB) | 143 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.